Advanced Solid Tumors
Showing 1 - 25 of >10,000
NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT
Recruiting
- Advanced Solid Tumors or Lymphomas
-
Changsha, Hunan, ChinaHunan Provincal Tumor Hospital
Oct 5, 2023
Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)
Not yet recruiting
- Advanced Solid Tumors With Neuroendocrine Differentiation
- (no location specified)
Nov 27, 2023
Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)
Not yet recruiting
- Advanced Solid Tumors
- B-cell Non-Hodgkin Lymphomas
- (no location specified)
Aug 31, 2023
HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor
Not yet recruiting
- HER2-expressing Advanced Solid Tumors
- SHR-A1811 combined with Pyrotinib.
- SHR-A1811 combined with other antitumor therapies
- (no location specified)
Aug 28, 2023
Advanced Solid Tumors Trial in Hangzhou (ZGGS15)
Not yet recruiting
- Advanced Solid Tumors
- ZGGS15
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
May 17, 2023
Advanced Solid Tumors Trial (ASKG915)
Not yet recruiting
- Advanced Solid Tumors
- ASKG915
- (no location specified)
May 10, 2023
Advanced Solid Tumors Trial in Guangzhou (MR001)
Not yet recruiting
- Advanced Solid Tumors
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Nov 12, 2023
Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))
Recruiting
- Advanced Solid Tumors
- Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
-
Hangzhou, ChinaFirst affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023
Advanced Solid Tumors Trial (SKB410 for injection)
Not yet recruiting
- Advanced Solid Tumors
- SKB410 for injection
- (no location specified)
Jun 13, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
May 12, 2023
GT316,Solid Tumors,Adult Trial in Zhengzhou (GT316)
Recruiting
- GT316,Solid Tumors,Adult
- GT316
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Oct 16, 2023
HER2-positive Advanced Solid Tumors Trial in Shanghai (DP303c)
Recruiting
- HER2-positive Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 10, 2023
Advanced Solid Tumors Trial in Jinan, Shanghai (PM1003 Injection)
Recruiting
- Advanced Solid Tumors
- PM1003 Injection
-
Jinan, Shandong, China
- +1 more
May 8, 2023
NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)
Not yet recruiting
- NSCLC
- +3 more
- YL202 should be intravenously infused
-
Chang chun, Jilin, ChinaJilin Provincial Cancer Hospital
Oct 25, 2023
Advanced Solid Tumor Trial in Guangzhou (YL-17231)
Recruiting
- Advanced Solid Tumor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 5, 2023